ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss DIN Q1 2026 Earnings EPS Surpasses Estimates by 529 Upstream Bio Inc UPB Q1 2026 Earnings Narrower Than Expected Loss Reflects Operational Discipline Koppers Holdings KOP Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance Guardian Pharmacy Services Q1 2026 Earnings EPS Miss Drags but Stock Holds Steady Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues BBGI Q4 2025 Earnings Deep Loss Reported as Stock Edges Higher Amid Sparse Data ORA Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance OBIO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline in PreRevenue Phase TeraWulf Inc Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges KZR Q1 2026 Earnings EPS Miss Highlights Cash Burn as Company Advances Pipeline BHP Q1 2026 Earnings EPS Misses Estimates Amid Cost and Commodity Pressures UPWK Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction